These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synthesis, molecular docking, and biological evaluation of some novel hydrazones and pyrazole derivatives as anti-inflammatory agents. Mohammed KO; Nissan YM Chem Biol Drug Des; 2014 Oct; 84(4):473-88. PubMed ID: 24720475 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of new nicotinate derivatives as potential anti-inflammatory agents targeting COX-2 enzyme. El-Dash Y; Khalil NA; Ahmed EM; Hassan MSA Bioorg Chem; 2021 Feb; 107():104610. PubMed ID: 33454504 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidines as anti-inflammatory agents. Tageldin GN; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM Bioorg Chem; 2018 Aug; 78():358-371. PubMed ID: 29627656 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidine derivatives bearing thiazolidinone moiety as anti-inflammatory agents. Tageldin GN; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM Bioorg Chem; 2018 Oct; 80():164-173. PubMed ID: 29929077 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation and docking study of a new series of di-substituted benzoxazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Kaur A; Pathak DP; Sharma V; Wakode S Bioorg Med Chem; 2018 Feb; 26(4):891-902. PubMed ID: 29373271 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of novel triarylpyrazoline derivatives as selective COX-2 inhibitors. Abdellatif KR; Abdelgawad MA; Labib MB; Zidan TH Bioorg Med Chem Lett; 2015 Dec; 25(24):5787-91. PubMed ID: 26546221 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of Hydroxybenzofuranyl-pyrazolyl and Hydroxyphenyl-pyrazolyl Chalcones and Their Corresponding Pyrazoline Derivatives as COX Inhibitors, Anti-inflammatory and Gastroprotective Agents. Ragab FAE; Mohammed EI; Abdel Jaleel GA; Selim AAMAE; Nissan YM Chem Pharm Bull (Tokyo); 2020; 68(8):742-752. PubMed ID: 32741915 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1-phenylpyrazolo[3,4-d]pyrimidine derivatives. Bakr RB; Azouz AA; Abdellatif KR J Enzyme Inhib Med Chem; 2016; 31(sup2):6-12. PubMed ID: 27210522 [TBL] [Abstract][Full Text] [Related]
11. Novel N-substituted 5-aminosalicylamides as dual inhibitors of cyclooxygenase and 5-lipoxygenase enzymes: Synthesis, biological evaluation and docking study. El-Nagar MKS; Abdu-Allah HHM; Salem OIA; Kafafy AN; Farghaly HSM Bioorg Chem; 2018 Aug; 78():80-93. PubMed ID: 29550533 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, anti-inflammatory screening, molecular docking, and COX-1,2/-5-LOX inhibition profile of some novel quinoline derivatives. Chaaban I; Rizk OH; Ibrahim TM; Henen SS; El-Khawass EM; Bayad AE; El-Ashmawy IM; Nematalla HA Bioorg Chem; 2018 Aug; 78():220-235. PubMed ID: 29602046 [TBL] [Abstract][Full Text] [Related]